This prompt is triggered when you select Kayexalate (polystyrene sulfonate) on the Medications order form. There are several potentially fatal contraindications against the administration of this drug. To respond:
Read the warning.
To review current FDA safety information on Kayexalate, click Link to FDA Warning. To return to the decision support form, click OK.
To review the article on UpToDate on the treatment and prevention of hyperkalemia, click Link to UpToDate Article. To return to the decision support form, click OK.
Review the list of absolute contraindications for Kayexalate (polystyrene sulfonate).
Click the Yes option to cancel the order because there is an absolute contraindication.
Click the No option if the patient has no absolute contraindications.
If you have not canceled the order due to absolute contraindications, review the alternative treatment recommendations.
Click the Yes option to cancel the Kayexalate order if an alternative is acceptable .
Click the No option if alternative treatments are not sufficient.
To return to the Medications Active Orders list without ordering, click Cancel Order (ALT+C).
If you do order Kayexalate, all of your selections are recorded for patient safety and quality assurance monitoring.